Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases
- PMID: 33705536
- DOI: 10.1093/ibd/izab052
Systematic Review of Inclusion and Analysis of Older Adults in Randomized Controlled Trials of Medications Used to Treat Inflammatory Bowel Diseases
Keywords: Crohn’s disease; aging; clinical trials; treatment; ulcerative colitis.
Similar articles
-
[Diet therapy in chronic inflammatory bowel disease: results from meta-analysis and randomized controlled trials].Praxis (Bern 1994). 2002 Nov 20;91(47):2041-9. doi: 10.1024/0369-8394.91.47.2041. Praxis (Bern 1994). 2002. PMID: 12501499 Review. German.
-
Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials.Expert Rev Gastroenterol Hepatol. 2023 May;17(5):469-477. doi: 10.1080/17474124.2023.2194631. Epub 2023 Apr 10. Expert Rev Gastroenterol Hepatol. 2023. PMID: 36961082
-
[Probiotics in inflammatory bowel disease: controlled trials and perspectives].Therapie. 2004 Jan-Feb;59(1):83-7. doi: 10.2515/therapie:2004017. Therapie. 2004. PMID: 15199674 Review. French.
-
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.
-
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
Cited by
-
Managing the older adult with inflammatory bowel disease: is age just a number?Curr Opin Gastroenterol. 2023 Jul 1;39(4):268-273. doi: 10.1097/MOG.0000000000000943. Epub 2023 May 23. Curr Opin Gastroenterol. 2023. PMID: 37265181 Free PMC article. Review.
-
Vedolizumab Is Associated With a Lower Risk of Serious Infections Than Anti-Tumor Necrosis Factor Agents in Older Adults.Clin Gastroenterol Hepatol. 2022 Jun;20(6):1299-1305.e5. doi: 10.1016/j.cgh.2021.08.047. Epub 2021 Sep 3. Clin Gastroenterol Hepatol. 2022. PMID: 34481954 Free PMC article.
-
Similar Efficacy of Mesalazine in Adult and Older Adult Ulcerative Colitis Patients: Post Hoc Analysis of a Randomized Noninferiority Trial of 1600 mg vs 400 mg Tablets.Inflamm Bowel Dis. 2025 Apr 10;31(4):975-982. doi: 10.1093/ibd/izae123. Inflamm Bowel Dis. 2025. PMID: 38902993 Free PMC article. Clinical Trial.
-
A Study of Patient Concerns in the Modern Therapeutic Era of Inflammatory Bowel Disease.Inflamm Bowel Dis. 2025 Jun 13;31(6):1595-1604. doi: 10.1093/ibd/izae197. Inflamm Bowel Dis. 2025. PMID: 39190809
-
The 5Ms of Geriatrics in Gastroenterology: The Path to Creating Age-Friendly Care for Older Adults With Inflammatory Bowel Diseases and Cirrhosis.Clin Transl Gastroenterol. 2022 Jan 12;13(1):e00445. doi: 10.14309/ctg.0000000000000445. Clin Transl Gastroenterol. 2022. PMID: 35080513 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources